Melanocortin 1 receptor (MC1R) has long been investigated as a promising target for metastatic melanoma drug delivery due to its overexpression in melanoma cells and relatively low expression in normal cells [45,46,47,48]. Here, MC1R is linked to metastatic melanoma.